Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

3.49
+0.02000.58%
Post-market: 3.490.0010+0.03%19:51 EDT
Volume:2.07M
Turnover:7.24M
Market Cap:1.06B
PE:-7.12
High:3.66
Open:3.52
Low:3.43
Close:3.47
52wk High:6.52
52wk Low:1.89
Shares:303.16M
Float Shares:202.75M
Volume Ratio:0.68
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4900
EPS(LYR):-0.4902
ROE:-14.47%
ROA:-9.99%
PB:1.09
PE(LYR):-7.12

Loading ...

A Look At AbCellera Biologics (ABCL) Valuation After Annual Earnings Reveal Higher Revenue And A Narrower Net Loss

Simply Wall St.
·
Mar 10

Major Investor Quietly Ramps Up Stake in AbCellera Biologics

TIPRANKS
·
Mar 03

Stock Track | AbCellera Biologics Soars 5.26% Intraday on Major Shareholder Acquisition

Stock Track
·
Mar 03

Insiders Quietly Double Down on AbCellera Biologics in Bold Buying Spree

TIPRANKS
·
Feb 28

Stock Track | AbCellera Biologics Soars 5.26% in After-Hours on Insider Buying by Major Shareholder and CFO

Stock Track
·
Feb 28

Thermopylae Holdings Ltd. Acquires AbCellera Biologics Common Shares

Reuters
·
Feb 28

AbCellera CFO Andrew Booth Acquires Common Shares

Reuters
·
Feb 28

Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks

TIPRANKS
·
Feb 26

AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts

TIPRANKS
·
Feb 26

Abcellera Biologics Inc : Piper Sandler Cuts Target Price to $12 From $16

THOMSON REUTERS
·
Feb 25

What Sparked AbCellera Biologics To Soar Over 9% After Hours

Benzinga
·
Feb 25

AbCellera Q4 revenue beats expectations

Reuters
·
Feb 25

AbCellera Biologics Q4 EPS $(0.03) Beats $(0.17) Estimate, Sales $44.900M Beat $6.351M Estimate

Benzinga
·
Feb 25

AbCellera reports FY25 EPS (49c) vs. (55c) last year

TIPRANKS
·
Feb 25

AbCellera FY 2025 revenue jumps 2.6x to USD 75.1 million

Reuters
·
Feb 25

BRIEF-AbCellera Q4 Revenue USD 44.9 Million Vs. IBES Estimate USD 6.06 Million

Reuters
·
Feb 25

Press Release: AbCellera Reports Full Year 2025 Business Results

Dow Jones
·
Feb 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 24

AbCellera Biologics to Present at Major Investor Conferences

Reuters
·
Feb 12

11 Stocks That Have Cratered and Look Like Buys -- Barrons.com

Dow Jones
·
Feb 10